PlumX Metrics
Embed PlumX Metrics

Tailored tetravalent antibodies potently and specifically activate wnt/frizzled pathways in cells, organoids and mice

eLife, ISSN: 2050-084X, Vol: 8
2019
  • 75
    Citations
  • 0
    Usage
  • 92
    Captures
  • 20
    Mentions
  • 7
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    75
  • Captures
    92
  • Mentions
    20
    • News Mentions
      20
      • News
        20
  • Social Media
    7
    • Shares, Likes & Comments
      7
      • Facebook
        7

Most Recent News

AntlerA antibody drug for treatment of vascular retinopathies

SAN FRANCISCO , June 9, 2021 /PRNewswire/ --  AntlerA has applied its next generation programmable ANT platform to develop therapeutics for treating retinopathies. Blood vessels

Article Description

Secreted Wnt proteins regulate development and adult tissue homeostasis by binding and activating cell-surface Frizzled receptors and co-receptors including LRP5/6. The hydrophobicity of Wnt proteins has complicated their purification and limited their use in basic research and as therapeutics. We describe modular tetravalent antibodies that can recruit Frizzled and LRP5/6 in a manner that phenocopies the activities of Wnts both in vitro and in vivo. The modular nature of these synthetic Frizzled and LRP5/6 Agonists, called FLAgs, enables tailored engineering of specificity for one, two or multiple members of the Frizzled family. We show that FLAgs underlie differentiation of pluripotent stem cells, sustain organoid growth, and activate stem cells in vivo. Activation of Wnt signaling circuits with tailored FLAgs will enable precise delineation of functional outcomes directed by distinct receptor combinations and could provide a new class of therapeutics to unlockthe promise of regenerative medicine.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know